Announcements Trials
Browse Landscape

Phase

Phase NA 84Phase 2 6Phase 2/3 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 170Neoplasm Metastasis 139Neoplasms 136Leukemia, Myeloid, Acute 133Colorectal Neoplasms 115Breast Neoplasms 115Melanoma 90Ovarian Neoplasms 88Prostatic Neoplasms 85Recurrence 83Multiple Myeloma 81Lung Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 71Pancreatic Neoplasms 70Myelodysplastic Syndromes 63Lymphoma, Non-Hodgkin 59Triple Negative Breast Neoplasms 53Glioma 53Stomach Neoplasms 49Endometrial Neoplasms 46Brain Neoplasms 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma, Large B-Cell, Diffuse 45Carcinoma, Renal Cell 45Small Cell Lung Carcinoma 44Lymphoma, Follicular 40Lymphoma, B-Cell 40Carcinoma, Hepatocellular 40Sarcoma 39

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Motor Activity × 90 days × Clear all
NCT07254793 2026-04-07

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

University of Arizona

Phase 1 Not yet recruiting
94 enrolled
LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡